Effect of Food on the Bioavailability of 15 mg Estetrol/3 mg Drospirenone Tablets in Healthy Female Volunteers
- First Posted Date
- 2016-08-02
- Last Posted Date
- 2016-08-02
- Lead Sponsor
- Estetra
- Target Recruit Count
- 28
- Registration Number
- NCT02852681
E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - EU/Russia Study
- First Posted Date
- 2016-06-29
- Last Posted Date
- 2019-10-04
- Lead Sponsor
- Estetra
- Target Recruit Count
- 1577
- Registration Number
- NCT02817828
- Locations
- 🇧🇪
Hopital Saint-Pierre, Bruxelles, Belgium
E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - United States/Canada Study
- First Posted Date
- 2016-06-29
- Last Posted Date
- 2020-02-10
- Lead Sponsor
- Estetra
- Target Recruit Count
- 2148
- Registration Number
- NCT02817841
- Locations
- 🇺🇸
Thomas Jefferson University Obstetrics and Gynecology, Philadelphia, Pennsylvania, United States
🇨🇦Clinique de Santé des Femmes, Quebec, Canada
Study Conducted to Further Understand the Elimination Pathways, Metabolite Profile and PK Profile of 14C-estetrol
- First Posted Date
- 2016-03-25
- Last Posted Date
- 2019-02-15
- Lead Sponsor
- Estetra
- Target Recruit Count
- 6
- Registration Number
- NCT02720224
- Locations
- 🇬🇧
Quotient Clinical, Ruddington, Nottingham, United Kingdom
Cycle Control Assessment of a Combined Oral Contraceptive Containing Estetrol and a Progestin P1 or P2
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-10-15
- Last Posted Date
- 2012-09-14
- Lead Sponsor
- Estetra
- Target Recruit Count
- 396
- Registration Number
- NCT01221831
- Locations
- 🇫🇮
Väestöliitto Oulu, Oulu, Finland
🇫🇮Tampereen Lääkärikeskus Oy, Tampere, Finland
🇫🇮Väestöliitto Turku, Turku, Finland
© Copyright 2024. All Rights Reserved by MedPath